Login / Signup

Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.

Helena IznardoE VilarrasaAnna López-FerrerLluis L Puig
Published in: The British journal of dermatology (2021)
Keyphrases
  • ankylosing spondylitis
  • free survival
  • adverse drug
  • atopic dermatitis
  • drug induced
  • emergency department